Adjuvant therapy after radical prostatectomy: clinical considerations.

Area of Science:

• Oncology
• Radiation Oncology
• Urology

Background:

• Current clinical practice lacks standardized guidelines for adjuvant radiotherapy following prostatectomy.
• Distinguishing adjuvant radiotherapy from salvage radiotherapy is challenging, impacting evidence interpretation.
• Identifying patients who benefit from immediate post-operative radiotherapy is crucial for judicious use and side-effect mitigation.

Purpose of the Study:

• To review pre- and post-surgical clinical considerations for adjuvant therapy after prostatectomy.
• To discuss the appropriate use of radiotherapy, androgen deprivation therapy, and chemotherapy.
• To outline principles for employing local and systemic therapies in the post-prostatectomy setting.

Main Methods:

• Literature review of pre- and post-surgical clinical considerations.
• Analysis of evidence regarding adjuvant radiotherapy, androgen deprivation therapy, and chemotherapy.
• Discussion of principles for local and systemic therapy application.

Main Results:

• The role of adjuvant radiotherapy post-prostatectomy is not well-defined.
• Difficulty in defining adjuvant radiotherapy and distinguishing it from salvage radiotherapy complicates evidence evaluation.
• Identifying appropriate candidates for adjuvant radiotherapy is essential.

Conclusions:

• Clearer criteria are needed to guide the use of adjuvant radiotherapy post-prostatectomy.
• Optimizing patient selection for adjuvant radiotherapy can improve outcomes and reduce toxicity.
• A comprehensive approach considering local and systemic therapies is necessary.